Content by Fortis Life Sciences

Polypharmacology allows scientists to explore novel therapeutic purposes for existing drugs and opens new doors to treat multifactorial diseases.

Get up to date on the next generation of rapid, point-of-care diagnostics. 

Scientists choose ELISAs for optimal sensitivity, specificity, accuracy, and reproducibility.

A roadmap to navigating flow cytometry

Understanding genetic mechanisms that alter cellular pathways.

A unique approach to antibody production that exposes antibody candidates to nucleosomes is revolutionizing best practices.

Identifying novel biomarkers of Parkinson’s disease enables early diagnosis and treatment monitoring.

Cancer immunotherapy targets the tumor microenvironment, blocking the molecular pathways that tumors exploit to prevent immune cell activity.